NASDAQ:SIEN
Delisted

Sientra Stock News

etoro logo Buy SIEN
*Your capital is at risk
$0.174
+0 (+0%)
At Close: May 20, 2024
The partnership builds on Sientra's safety profile by empowering surgeons with Butterfly Network's cutting-edge point-of-care ultrasound technology to screen and evaluate patients with breast implants
Investors often look to top fund managers to glean information on the best strategies and generate new investment ideas.
Sientra's (SIEN) CEO Ron Menezes on Q4 2020 Results - Earnings Call Transcript
Sientra (SIEN) delivered earnings and revenue surprises of -15.15% and 0.20%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
SANTA BARBARA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today an

Sientra Earnings Preview

10:07am, Wednesday, 10'th Mar 2021
Sientra (NASDAQ:SIEN) announces its next round of earnings this Thursday, March 11. Here is Benzinga's look at Sientra's Q4 earnings report.
Sientra (SIEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SANTA BARBARA, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today ann
Sientra Inc (NASDAQ: SIEN) prices its previously announced underwritten public offering of 5.4 million common shares at $6.75 per share, with gross proceeds of approximately $36.5 million. The off
SANTA BARBARA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today ann
SANTA BARBARA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today ann

Why Sientra Stock Is Soaring Today

01:35pm, Friday, 05'th Feb 2021
The company released preliminary results for its fourth quarter.
Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth
Sientra, Inc. (SIEN) CEO Ron Menezes on Q3 2020 Results - Earnings Call Transcript
Reports record Breast Products net sales of $15.3 million, representing 54% sequential growth and 2 1 % year over year growth
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE